---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-002336"
form_type: "8-K"
ticker: null
cik: "0001848948"
company_name: "10X Capital Venture Acquisition Corp. III"
filed_at: "2024-01-09T23:59:59+00:00"
generated_at: "2026-06-07T01:41:09.554393+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# 10X Capital Venture Acquisition Corp. III announces CEO and President changes; Weisburd named CEO, Ahmed President

## Summary
- CEO Hans Thomas departed Jan 9, 2024; remains Chairman of the Board.
- David Weisburd appointed CEO, previously COO and Head of Origination.
- President Oliver Wriedt departed; Osman Ahmed appointed President.
- Ahmed executed joinder to insider letter agreement and indemnity agreement.
- Merger with American Gene Technologies (Addimmune) remains pending; S-4 filed.

## SEC filing metadata
- accession: 0001213900-24-002336
- form_type: 8-K
- cik: 0001848948
- company_name: 10X Capital Venture Acquisition Corp. III
- filed_at: 2024-01-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1848948/000121390024002336/0001213900-24-002336-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1848948/000121390024002336/ea191405-8k425_10xcap3.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-002336
- JSON: https://secwatch.observer/filing/0001213900-24-002336.json
- Plain text: https://secwatch.observer/filing/0001213900-24-002336.txt

## Key facts
- Executive change
  Osman Ahmed was appointed as President at 10X Capital Venture Acquisition Corp. III.
  - Action: appointed
  - Role: President
  source text: On January 9, 2024, the Board appointed Osman Ahmed as 10X III’s President, effective January 9, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848948/000121390024002336/0001213900-24-002336-index.htm
- Executive change
  Oliver Wriedt departed as President and Head of Capital Markets at 10X Capital Venture Acquisition Corp. III.
  - Action: departed
  - Role: President and Head of Capital Markets
  source text: On January 9, 2024, Oliver Wriedt and 10X III agreed that Mr. Wriedt will no longer serve as 10X III’s President and Head of Capital Markets, effective January 9, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848948/000121390024002336/0001213900-24-002336-index.htm
- Executive change
  Hans Thomas departed as Chief Executive Officer at 10X Capital Venture Acquisition Corp. III.
  - Action: departed
  - Role: Chief Executive Officer
  source text: On January 9, 2024, Hans Thomas and 10X Capital Venture Acquisition Corp. III (“10X III”) agreed that Mr. Thomas will no longer serve as 10X III’s Chief Executive Officer, effective January 9, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848948/000121390024002336/0001213900-24-002336-index.htm
- Executive change
  David Weisburd was appointed as Chief Executive Officer at 10X Capital Venture Acquisition Corp. III.
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On January 9, 2024, the Board appointed David Weisburd as 10X III’s Chief Executive Officer, effective January 9, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848948/000121390024002336/0001213900-24-002336-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.